Clinicopathological features and prognosis of primary pulmonary rhabdomyosarcoma in middle-aged and elderly patients : a case report and literature review

To date, only 34 cases of primary pulmonary rhabdomyosarcoma (PPRMS) in the middle-aged and elderly population have been published. However, analyses of the clinicopathological characteristics and prognosis of PPRMS in this population have not been performed. A 75-year-old man visited our hospital because of abdominal pain and discomfort. His serum lactate dehydrogenase, neuron specific enolase, and progastrin-releasing peptide levels were elevated. Positron emission tomography-computed tomography revealed a lobulated mass of 7.6 × 5.5 cm2 in the lower lobe of the left lung with abnormally high fluoro-2-deoxy-d-glucose metabolism. Histologically, the tumor cells were small with little cytoplasm, deep nuclear staining, and heavily stained nuclear chromatin. Immunohistochemically, the tumor cells were positive for desmin, MyoD1 myogenin, synaptophysin, and CD56. Cytogenetic analysis for FOXO1A translocation was negative. Finally, the patient was diagnosed with PPRMS. He received combined chemotherapy with vincristine 1 mg, actinomycin 0.4 mg, cyclophosphamide 0.8 mg; however, only one course of chemotherapy was completed, and the patient died 2 months after diagnosis. PPRMS in middle-aged and elderly people is a highly malignant soft tissue tumor with significant clinicopathological characteristics.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:51

Enthalten in:

The Journal of international medical research - 51(2023), 3 vom: 15. März, Seite 3000605231159782

Sprache:

Englisch

Beteiligte Personen:

Xiaoxia, Jin [VerfasserIn]
Guihua, Zheng [VerfasserIn]
Jiatai, Wang [VerfasserIn]
Xinghua, Zhu [VerfasserIn]
Xudong, Chen [VerfasserIn]
Yingze, Wei [VerfasserIn]

Links:

Volltext

Themen:

1CC1JFE158
5J49Q6B70F
8N3DW7272P
Case Reports
Case report
Clinicopathological
Cyclophosphamide
Dactinomycin
Elderly
Journal Article
Mesenchymal tumor
Middle-aged
Primary pulmonary rhabdomyosarcoma
Prognosis
Review
Skeletal muscle
Vincristine

Anmerkungen:

Date Completed 10.03.2023

Date Revised 12.03.2023

published: Print

Citation Status MEDLINE

doi:

10.1177/03000605231159782

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353891975